Meridian Bioscience Stock News

AA, HLI, RUSHA, COLM, and VIVO have been added to the Zacks Rank #1 (Strong Buy) List on March 22, 2022.

Meridian Bioscience and NeuroPace have been highlighted as Zacks Bull and Bear of the Day.

Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns

Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns

These two overlooked healthcare stocks are underpriced and provide solid, long-term opportunity.

These two overlooked healthcare stocks are underpriced and provide solid, long-term opportunity.

Meridian Bioscience, Innoviva, Horace Mann Educators and Maravai LifeSciences are included in this blog.

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.

Photo by 张 嘴 on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Despite COVID-19 and supply-chain issues, the Chinese smartphone market continues to grow. Apple Inc. (NASDAQ: AAPL ), which shipped 50 million new phones in 2021, led the pack, followed closely by Meridian Bioscience Inc. ’s (NASDAQ: VIVO ) Vivo Mobile . According to a study by McGill University in Montreal, Quebec, China continues to have the most smartphones in the world with more than 900 million users. With cell phones continuing to be part of daily life in China, which has the most access to 5G in the world, companies like FingerMotion Inc. (Nasdaq: FNGR ) and its mobile payment and recharge platforms continue to be a growing solution provider for the nation’s users. FingerMotion recently announced its shares of common stock are listed and available for trading on the Nasdaq Capital Market under the ticker symbol FNGR. “Listing on Nasdaq provides us greater exposure within the investment community as we execute on our ambitious growth strategies and key upcoming milestones, including expansion into …

Meridian Bioscience Inc. (NASDAQ:VIVO) has a beta value of 0.42 and has seen 0.51 million shares traded in the last trading session. The company, currently valued at $1.08B, closed the last trade at $24.74 per share which meant it lost -$0.46 on the day or -1.83% during that session. The VIVO stock price is -20.21% Meridian Bioscience Inc. Is A Buy Small Cap Stock: Analysts Read More »

We identified 18 stocks in S&P 500 with strong momentum based on our criteria. Ten of the stocks we identified made new all-time highs.

Impactive recently disclosed a stake in the life science company. The activist fund has built a reputation for its approach toward ESG investing.